Thomas Kudsk Larsen
Head of IR North America
Thomas Kudsk Larsen is Head, Investor Relations North America at Swiss biopharmaceutical and diagnostics company Roche and Vice President of Roche Holdings, Inc. Thomas is based at Genentech, Inc., a member of the Roche Group in South San Francisco, California responsible for Roche Group investor relations in The Americas.
Before joining Roche in 2005, Thomas was Manager, Investor Relations, Novozymes A/S, based in North Carolina, USA (2004-2005) and Manager, Investor Relations, Novozymes A/S, a danish industrial biotech company, based in Denmark (2001-2004). From 2000-2001, Thomas was Financial Analyst, Novo Nordisk Pharma Ltd., Tokyo, Japan and served in various Finance positions 1995-2000 at Novo Nordisk A/S, Denmark.
Thomas holds an HD in Finance from Copenhagen Business School and is a native of Denmark.
In the 2012 European Investor Relations Perception Study by Institutional Investor, Roche was ranked first in Best Investor Relations, Pharmaceuticals by U.S. investors. In 2011, Roche won Best investor relations by a European company in the U.S. by IR magazine.
*subject to change
Contact Tammy Dang (email@example.com) with session inquiries.